EVAX
Evaxion Biotech A/S
NASDAQ · Healthcare · Biotechnology · DK
$3.12
+1.30%Margins
Gross margin
100.0%
EBITDA margin
-132.5%
EBIT margin
-116.0%
Net margin
-115.5%
FCF margin
0.0%
-90.8%
Return on equity
-44.6%
Return on assets
-52.2%
Return on invested capital
0.35x
Asset turnover
$0.00
Cash from operations
$1.68
Cash per share
Margins, returns on capital and operating efficiency from the latest trailing period · Data as of Jun 1, 2026